Apply for Behavioral Research Grants

If you are interested in grants for behavioral research in cancer prevention and control, review this selection of funding opportunity announcements.


Apply for Funding

Title Announcement # Expiration Date Contact
NIH Research Project Grant PA-20-185 (Parent R01 Clinical Trial Not Allowed) May 8, 2023 View the BRP staff directory to identify Program Directors by research area and Branch assignment
NCI Small Grants Program for Cancer Research PAR-20-052 (R03 Clinical Trial Optional) January 8, 2023 Research Program Contacts
Modular R01s in Cancer Control and Population Sciences

Helpful Resources
PAR-18-869 (R01 Clinical Trial Optional) March 9, 2021 Scott Rogers
240-276-6932
rogerssc@mail.nih.gov
Cancer Prevention and Control Clinical Trials Grant Program

View Active BRP Grants
PAR-18-559 (R01 Clinical Trial Required) January 8, 2021 Susan Czajkowski
240-276-5871
Susan.Czajkowski@nih.gov
Academic Research Enhancement Award PA-18-343 (R15 Clinical Trial Required) January 8, 2021 Robin Vanderpool
240-276-6558
robin.vanderpool@nih.gov
Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) Programs at the National Institutes of Health Gurvaneet Randhawa
240-276-6940
gurvaneet.randhawa@nih.gov

Patrica Weber
weberpa@mail.nih.gov

See information about NCI Small Grants Program for Cancer Research (NCI Omnibus) and NIH Research Project Grants

Title Announcement # Expiration Date Contact
Advancing Research to Develop Improved Measures and Methods for Understanding Multimorbidity PAR-20-179 (R01 Clinical Trial Optional) September 08, 2023 Bryan Kim
240-276-6669
bryan.kim@nih.gov
Identifying Innovative Mechanisms or Interventions that Target Multimorbidity and Its Consequences PAR-20-180 (R01 Clinical Trial Optional) September 08, 2023 Bryan Kim
240-276-6669
bryan.kim@nih.gov
Notice of Special Interest: Research on Oral Anticancer Agents in the Contexts of Utilization, Adherence, and Health Care Delivery

Register for May 18 webinar
NOT-CA-20-026 May 8, 2023 Wendy Nelson
240-276-6971
nelsonw@mail.nih.gov
Fundamental Mechanisms of Affective and Decisional Processes in Cancer Control

View Active BRP Grants
PAR-20-034 (R01 Clinical Trial Optional) January 8, 2023 Rebecca Ferrer
301-852-1167
rebecca.ferrer@nih.gov
Perception and Cognition Research to Inform Cancer Image Interpretation

Helpful Resources

View Active BRP Grants
PAR-19-387 (R01 Clinical Trial Optional)
PAR-19-389 (R21 Clinical Trial Optional)
January 8, 2023 Todd Horowitz
240-276-6963
horowitzts@mail.nih.gov
Leveraging Cognitive Neuroscience Research to Improve Assessment of Cancer Treatment-Related Cognitive Impairment

View Active BRP Grants

PAR-19-340 (R01 Clinical Trial Optional)

PAR-19-339 (R21 Clinical Trial Optional)
June 9, 2022 Todd Horowitz
240-276-6963
horowitzts@mail.nih.gov
Neural Regulation of Cancer PAR-19-353 (R01 Clinical Trial Not Allowed)
PAR-19-354 (R21 Clinical Trial Not Allowed)
May 28, 2022 Chamelli Jhappan
jhappanc@mail.nih.gov

Paige Green
240-276-6899
paige.green@nih.gov
Research on biopsychosocial factors of social connectedness and isolation on health, wellbeing, illness, and recovery

Notice of Additional Due Date and Additional “Areas of Focus Especially of Interest”
PAR-19-373 (R01 Clinical Trials Not Allowed)

PAR-19-384 ((R01 Basic Experimental Studies with Humans Required)

NOT-OD-20-103
March 18, 2021 Rebecca Ferrer
301-852-1167
rebecca.ferrer@nih.gov

See information about NCI Small Grants Program for Cancer Research (NCI Omnibus) and NIH Research Project Grants

Title Announcement # Expiration Date Contact
Alcohol and Cancer Control NOT-CA-20-034 September 9, 2023 Tanya Agurs-Collins
240-276-6956
collinsta@nih.gov

David Berrigan
240-276-6752
berrigad@nih.gov
Notice of Special Interest (NOSI): Development and Preliminary Testing of Health-related Behavioral Interventions NOT-OD-20-106 September 26, 2022 Susan Czajkowski
240-276-5871
Susan.Czajkowski@nih.gov
Stimulating Innovations in Behavioral Intervention Research for Cancer Prevention and Control

Helpful Resources
PAR-19-309 (R21 Clinical Trial Optional) September 8, 2022 Tanya Agurs-Collins
240-276-6956
collinsta@mail.nih.gov
Geospatial Approaches in Cancer Control and Population Sciences NOT-CA-20-004 January 8, 2022 Robin Vanderpool
240-276-6558
robin.vanderpool@nih.gov

David Berrigan
240-276-6752
David.Berrigan@nih.gov
Time-Sensitive Obesity Policy and Program Evaluation PAR-18-854 (R01 Clinical Trial Not Allowed) September 11, 2021 David Berrigan
240-276-6752 berrigad@mail.nih.gov
Physical Activity and Weight Control Interventions Among Cancer Survivors: Effects on Biomarkers of Prognosis and Survival

View Active BRP Grants
PAR-18-893 (R01 Clinical Trial Optional)
PAR-18-892 (R21 Clinical Trial Optional)
September 8, 2021 Frank Perna
240-276-6782
pernafm@mail.nih.gov
Age-related Microbiota Changes and their Implications in Chronic Disease Prevention, Treatment and Progression

PA-18-738 (R01 Clinical Trial Optional)
PA-18-739 (R21 Clinical Trial Optional)

May 8, 2021 Tanya Agurs-Collins
240-276-6956
collinsta@mail.nih.gov
Exploratory/Developmental Clinical Research Grants in Obesity PA-18-720 (R21 Clinical Trial Optional) May 8, 2021 Tanya Agurs-Collins
240-276-6956
collinsta@mail.nih.gov
Testing and Developing Interventions for Health-Enhancing Physical Activity

Helpful Resources
Testing: PAR-18-324 (R01 - Clinical Trial Optional)

Developing: PAR-18-307 (R21/R33 Clinical Trial Optional)
January 8, 2021 Frank Perna
240-276-6782
pernafm@mail.nih.gov

See information about NCI Small Grants Program for Cancer Research (NCI Omnibus) and NIH Research Project Grants

Title Announcement # Expiration Date Contact
Innovative Approaches to Studying Cancer Communication in the New Information Ecosystem

Ethical Considerations for Social Media Research (PDF)

View Active BRP Grants

PAR-19-348 (R01 Clinical Trial Optional)
PAR-19-350 (R21 Clinical Trial Optional)
June 9, 2022 Kelly Blake
240-281-5934
kelly.blake@nih.gov
Mechanism for Time-Sensitive Drug Abuse Research PAR-19-064 (R21 Clinical Trial Optional)

NOT-CA-19-015
November 9, 2021

Kelly Blake
240-281-5934
kelly.blake@nih.gov

End-of-Life and Palliative Care Health Literacy: Improving Outcomes in Serious, Advanced Illness PA-18-498 (R01 Clinical Trial Optional)
PA-18-499 (R21 Clinical Trial Optional)
May 8, 2021 Wen-Ying Sylvia Chou
240-276-6954
chouws@mail.nih.gov
Leveraging Health Information Technology (Health IT) to Address Minority Health and Health Disparities PAR-19-093 (R01 Clinical Trial Optional) March 5, 2021 Robin Vanderpool
240-276-6558
robin.vanderpool@nih.gov
NIH Guide Notice on NIH-NSF joint funding opportunity, "Smart and Connected Health" Robin Vanderpool
240-276-6558
robin.vanderpool@nih.gov

See information about NCI Small Grants Program for Cancer Research (NCI Omnibus) and NIH Research Project Grants

TCRB Funding Opportunity Announcements (PDF, 440 KB), February 2020

Title Announcement # Expiration Date Contact
Notice of NCI's Participation on PAR-19-368, Accelerating the Pace of Drug Abuse Research Using Existing Data

NOT-CA-20-061 (R01 Clinical Trial Optional)

September 8, 2021 Carolyn Reyes-Guzman
240-276-7244
reyesguzmancm@mail.nih.gov
Integrative Research on Polysubstance Abuse and Disorder PAR-20-035 (R61/R33 Clinical Trial Optional) November 8, 2022 Annette Kaufman
240-276-6706
kaufmana@mail.nih.gov

David Berrigan
240-276-6752
berrigad@mail.nih.gov
Pathway to Independence Award in Tobacco Regulatory Research RFA-OD-20-010 (K99/R00 - Independent Clinical Trial Required)
RFA-OD-20-009 (K99/R00 - Independent Clinical Trial Not Allowed)
July 11, 2022 Rachel Grana Mayne
240-276-5899
rachel.mayne@nih.gov
Mentored Research Scientist Career Development Award in Tobacco Regulatory Research RFA-OD-20-011 (K01 - Independent Clinical Trial Required)
RFA-OD-20-008 (K01 - Independent Clinical Trial Not Allowed)
July 11, 2022 Rachel Grana Mayne
240-276-5899
rachel.mayne@nih.gov
Notice of Special Interest (NOSI): Dissemination and Implementation Science for Cancer Prevention and Control in Low Resource Environments NOT-CA-20-025 May 8, 2022 Mark Parascandola
240-276-6871
paramark@mail.nih.gov
Mechanism for Time-Sensitive Drug Abuse Research PAR-19-064 (R21 Clinical Trial Optional)

NOT-CA-19-015
November 9, 2021 Kelly Blake
240-281-5934
kelly.blake@nih.gov
Accelerating the Pace of Child Health Research Using Existing Data from the Adolescent Brain Cognitive Development (ABCD) Study PAR-19-162 (R01 Clinical Trial Not Allowed)
PAR-19-163 (R21 Clinical Trial Not Allowed)
September 8, 2021 Annette Kaufman
240-276-6706
kaufmana@mail.nih.gov
Maximizing the Scientific Value of Existing Biospecimen Collections RFA-OD-19-021 (R21 Clinical Trial Not Allowed) March 9, 2021 Rachel Grana Mayne
240-276-5899
rachel.mayne@nih.gov
Secondary Analyses of Existing Datasets of Tobacco Use and Health RFA-OD-19-022 (R21 Clinical Trial Not Allowed) March 9, 2021 Rachel Grana Mayne
240-276-5899
rachel.mayne@nih.gov
Tobacco Regulatory Science

View Active BRP Grants
RFA-OD-19-028 (R01 Clinical Trial Optional) February 14, 2021 Rachel Grana Mayne
240-276-5899
rachel.mayne@nih.gov
Notice of Special Interest: Research to Advance the Understanding of Tobacco Product Pharmacokinetic Research NOT-OD-20-081 February 13, 2021 Rachel Grana Mayne
240-276-5899
rachel.mayne@nih.gov
Multi-Site Studies for System-Level Implementation of Substance Use Prevention and Treatment Services PAR-18-222 (R01 Clinical Trial Optional) November 14, 2020 Michele Bloch
240-276-6878
blochm@mail.nih.gov
Electronic Nicotine Delivery Systems (ENDS): Basic Mechanisms of Health Effects PAR-18-845 (R01 Clinical Trial Not Allowed)
PAR-18-846 (R21 Clinical Trial Not Allowed)
June 28, 2020 Ron Johnson
240-276-6228 
rjohnso2@mail.nih.gov
Electronic Nicotine Delivery Systems (ENDS): Population, Clinical and Applied Prevention Research PAR-18-847 (R01 Clinical Trial Optional)
PAR-18-848 (R21 Clinical Trial Optional)
June 28, 2020 For cancer-related FOA questions:
Rachel Grana Mayne
240-276-5899
rachel.mayne@nih.gov

For general FOA questions:
Dionne Godette-Greer
Office of Disease Prevention (ODP)
301-480-1161
dionne.godette@nih.gov
U.S. Tobacco Control Policies to Reduce Health Disparities

Helpful Resources

View Active BRP Grants
PAR-18-675 (R01 Clinical Trial Optional)
PAR-18-674 (R21 Clinical Trial Optional)
June 16, 2020 Bob Vollinger
240-276-6919
bob.vollinger@nih.gov
Public Policy Effects on Alcohol-, Marijuana-, and Other Substance-Related Behaviors and Outcomes PA-17-135 (R01)
(NOT-AA-20-010)

PA-17-132 (R21)
(NOT-AA-20-008)

PA-17-134 (R03)
(NOT-AA-20-009)
September 8, 2020 Carolyn Reyes-Guzman
240-276-7244
reyesguzmancm@mail.nih.gov
Tobacco Use and HIV in Low and Middle Income Countries

Helpful Resources

View Active BRP Grants
PAR-18-023 (R01 Clinical Trial Optional)
PAR-18-022 (R21 Clinical Trial Optional)
January 8, 2020 Mark Parascandola
240-276-6871
paramark@mail.nih.gov

View Current and Past Behavioral Research Grants


Other Funding Opportunities

Need Help?

Contact BRP staff by email or phone. BRP Staff Directory

Explore Funding History

DCCPS provides detailed information about funded program announcement initiatives, request for application initiatives, and trends.